Mortality benefit of a comprehensive heart failure disease management program in indigent patients
Heart failure (HF) produces significant morbidity and mortality. Although HF disease management (HFDM) programs have been shown to decrease this morbidity, there is still a paucity of data on their effect on mortality. The objective of this study was to determine whether participation in an HFDM pro...
Gespeichert in:
Veröffentlicht in: | The American heart journal 2006-02, Vol.151 (2), p.478-483 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 483 |
---|---|
container_issue | 2 |
container_start_page | 478 |
container_title | The American heart journal |
container_volume | 151 |
creator | Hebert, Kathy A. Horswell, Ronald L. Dy, Sydney Key, Ira J. Butler, Michael K. Cerise, Frederick P. Arcement, Lee M. |
description | Heart failure (HF) produces significant morbidity and mortality. Although HF disease management (HFDM) programs have been shown to decrease this morbidity, there is still a paucity of data on their effect on mortality. The objective of this study was to determine whether participation in an HFDM program would reduce mortality in an indigent population from rural Louisiana.
Proportional hazards modeling was used to determine whether patients participating in the HFDM program had improved survival compared with patients receiving traditional outpatient care at the same institution. Inclusion criteria consisted of an index hospitalization with discharge occurring between July 1, 1997, and May 30, 2002, hospital discharge diagnosis of HF, left ventricular systolic dysfunction documented during hospitalization, and at least 1 subsequent outpatient visit. Data from patients having participated in the HFDM program before their index hospitalization were excluded.
Compared with patients who were given traditional care (n = 100), HFDM patients (n = 156) were younger (56.7 vs 60 years,
P = .031), more likely to be African American (48.7% vs 33.0%,
P = .014), more likely to be uninsured (47.4% vs 27%,
P = .001), and more likely to have an ejection fraction of ≤25% (73.1% vs 36%,
P < .001). Overall comorbidity did not differ significantly between the groups. After controlling for differences in demographics, ejection fraction, and comorbidities, participation in the HFDM program was associated with a significant reduction in mortality compared with traditional care (adjusted hazard ratio .33,
P < .001).
In this indigent population, participation in an HFDM program was associated with decreased mortality compared with traditional follow-up care. |
doi_str_mv | 10.1016/j.ahj.2005.04.022 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70718205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870305004412</els_id><sourcerecordid>70718205</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-eda09d76067f437bbbbfc9ec83c13dc7fa1290c511f217a55dae89707fcc08943</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVpaLZpf0AvRVDam52RLEs2PYXQL0jIpT2LWXm0K-OPrWQH8u-r7S4EeqgQDBLPvLw8jL0TUAoQ-rovcd-XEqAuQZUg5Qu2EdCaQhulXrINAMiiMVBdstcp9fmpZaNfsUuhlZKtaDZsez_HBYewPPEtTeTDwmfPkbt5PETa05TCI_E9YVy4xzCskXgXEmEiPuKEOxppWvghzruIIw9Tvl3Y_f3DJeSZ3rALj0Oit-d5xX59_fLz9ntx9_Dtx-3NXeEUtEtBHULbGQ3aeFWZbT7eteSayomqc8ajkC24WggvhcG67pCa1oDxzkHTquqKfTrl5jK_V0qLHUNyNAw40bwmm1HRSKgz-OEfsJ_XOOVuVtSgtIRWH-PEiXJxTimSt4cYRoxPVoA96re9zfrtUb8FZbP-vPP-nLxuR-qeN86-M_DxDGByOPiIkwvpmTOq0VrozH0-cZSFPQaKNrks01EXIrnFdnP4T40_C9ajMA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504620964</pqid></control><display><type>article</type><title>Mortality benefit of a comprehensive heart failure disease management program in indigent patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hebert, Kathy A. ; Horswell, Ronald L. ; Dy, Sydney ; Key, Ira J. ; Butler, Michael K. ; Cerise, Frederick P. ; Arcement, Lee M.</creator><creatorcontrib>Hebert, Kathy A. ; Horswell, Ronald L. ; Dy, Sydney ; Key, Ira J. ; Butler, Michael K. ; Cerise, Frederick P. ; Arcement, Lee M.</creatorcontrib><description>Heart failure (HF) produces significant morbidity and mortality. Although HF disease management (HFDM) programs have been shown to decrease this morbidity, there is still a paucity of data on their effect on mortality. The objective of this study was to determine whether participation in an HFDM program would reduce mortality in an indigent population from rural Louisiana.
Proportional hazards modeling was used to determine whether patients participating in the HFDM program had improved survival compared with patients receiving traditional outpatient care at the same institution. Inclusion criteria consisted of an index hospitalization with discharge occurring between July 1, 1997, and May 30, 2002, hospital discharge diagnosis of HF, left ventricular systolic dysfunction documented during hospitalization, and at least 1 subsequent outpatient visit. Data from patients having participated in the HFDM program before their index hospitalization were excluded.
Compared with patients who were given traditional care (n = 100), HFDM patients (n = 156) were younger (56.7 vs 60 years,
P = .031), more likely to be African American (48.7% vs 33.0%,
P = .014), more likely to be uninsured (47.4% vs 27%,
P = .001), and more likely to have an ejection fraction of ≤25% (73.1% vs 36%,
P < .001). Overall comorbidity did not differ significantly between the groups. After controlling for differences in demographics, ejection fraction, and comorbidities, participation in the HFDM program was associated with a significant reduction in mortality compared with traditional care (adjusted hazard ratio .33,
P < .001).
In this indigent population, participation in an HFDM program was associated with decreased mortality compared with traditional follow-up care.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2005.04.022</identifier><identifier>PMID: 16442918</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Biological and medical sciences ; Cardiology. Vascular system ; Disease Management ; Drug therapy ; Female ; Heart ; Heart attacks ; Heart Failure - drug therapy ; Heart Failure - economics ; Heart Failure - mortality ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Hospitalization ; Hospitals ; Humans ; Louisiana - epidemiology ; Male ; Medical sciences ; Middle Aged ; Mortality ; Odds Ratio ; Poverty - statistics & numerical data ; Program Evaluation ; Proportional Hazards Models ; Retrospective Studies ; Survival Analysis ; Ventricular Dysfunction, Left - drug therapy ; Ventricular Dysfunction, Left - economics ; Ventricular Dysfunction, Left - mortality</subject><ispartof>The American heart journal, 2006-02, Vol.151 (2), p.478-483</ispartof><rights>2006 Mosby, Inc.</rights><rights>2006 INIST-CNRS</rights><rights>Copyright Elsevier Limited Feb 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-eda09d76067f437bbbbfc9ec83c13dc7fa1290c511f217a55dae89707fcc08943</citedby><cites>FETCH-LOGICAL-c409t-eda09d76067f437bbbbfc9ec83c13dc7fa1290c511f217a55dae89707fcc08943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002870305004412$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17486616$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16442918$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hebert, Kathy A.</creatorcontrib><creatorcontrib>Horswell, Ronald L.</creatorcontrib><creatorcontrib>Dy, Sydney</creatorcontrib><creatorcontrib>Key, Ira J.</creatorcontrib><creatorcontrib>Butler, Michael K.</creatorcontrib><creatorcontrib>Cerise, Frederick P.</creatorcontrib><creatorcontrib>Arcement, Lee M.</creatorcontrib><title>Mortality benefit of a comprehensive heart failure disease management program in indigent patients</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Heart failure (HF) produces significant morbidity and mortality. Although HF disease management (HFDM) programs have been shown to decrease this morbidity, there is still a paucity of data on their effect on mortality. The objective of this study was to determine whether participation in an HFDM program would reduce mortality in an indigent population from rural Louisiana.
Proportional hazards modeling was used to determine whether patients participating in the HFDM program had improved survival compared with patients receiving traditional outpatient care at the same institution. Inclusion criteria consisted of an index hospitalization with discharge occurring between July 1, 1997, and May 30, 2002, hospital discharge diagnosis of HF, left ventricular systolic dysfunction documented during hospitalization, and at least 1 subsequent outpatient visit. Data from patients having participated in the HFDM program before their index hospitalization were excluded.
Compared with patients who were given traditional care (n = 100), HFDM patients (n = 156) were younger (56.7 vs 60 years,
P = .031), more likely to be African American (48.7% vs 33.0%,
P = .014), more likely to be uninsured (47.4% vs 27%,
P = .001), and more likely to have an ejection fraction of ≤25% (73.1% vs 36%,
P < .001). Overall comorbidity did not differ significantly between the groups. After controlling for differences in demographics, ejection fraction, and comorbidities, participation in the HFDM program was associated with a significant reduction in mortality compared with traditional care (adjusted hazard ratio .33,
P < .001).
In this indigent population, participation in an HFDM program was associated with decreased mortality compared with traditional follow-up care.</description><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Disease Management</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - economics</subject><subject>Heart Failure - mortality</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Louisiana - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Odds Ratio</subject><subject>Poverty - statistics & numerical data</subject><subject>Program Evaluation</subject><subject>Proportional Hazards Models</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><subject>Ventricular Dysfunction, Left - drug therapy</subject><subject>Ventricular Dysfunction, Left - economics</subject><subject>Ventricular Dysfunction, Left - mortality</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kE1r3DAQhkVpaLZpf0AvRVDam52RLEs2PYXQL0jIpT2LWXm0K-OPrWQH8u-r7S4EeqgQDBLPvLw8jL0TUAoQ-rovcd-XEqAuQZUg5Qu2EdCaQhulXrINAMiiMVBdstcp9fmpZaNfsUuhlZKtaDZsez_HBYewPPEtTeTDwmfPkbt5PETa05TCI_E9YVy4xzCskXgXEmEiPuKEOxppWvghzruIIw9Tvl3Y_f3DJeSZ3rALj0Oit-d5xX59_fLz9ntx9_Dtx-3NXeEUtEtBHULbGQ3aeFWZbT7eteSayomqc8ajkC24WggvhcG67pCa1oDxzkHTquqKfTrl5jK_V0qLHUNyNAw40bwmm1HRSKgz-OEfsJ_XOOVuVtSgtIRWH-PEiXJxTimSt4cYRoxPVoA96re9zfrtUb8FZbP-vPP-nLxuR-qeN86-M_DxDGByOPiIkwvpmTOq0VrozH0-cZSFPQaKNrks01EXIrnFdnP4T40_C9ajMA</recordid><startdate>20060201</startdate><enddate>20060201</enddate><creator>Hebert, Kathy A.</creator><creator>Horswell, Ronald L.</creator><creator>Dy, Sydney</creator><creator>Key, Ira J.</creator><creator>Butler, Michael K.</creator><creator>Cerise, Frederick P.</creator><creator>Arcement, Lee M.</creator><general>Mosby, Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20060201</creationdate><title>Mortality benefit of a comprehensive heart failure disease management program in indigent patients</title><author>Hebert, Kathy A. ; Horswell, Ronald L. ; Dy, Sydney ; Key, Ira J. ; Butler, Michael K. ; Cerise, Frederick P. ; Arcement, Lee M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-eda09d76067f437bbbbfc9ec83c13dc7fa1290c511f217a55dae89707fcc08943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Disease Management</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - economics</topic><topic>Heart Failure - mortality</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Louisiana - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Odds Ratio</topic><topic>Poverty - statistics & numerical data</topic><topic>Program Evaluation</topic><topic>Proportional Hazards Models</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><topic>Ventricular Dysfunction, Left - drug therapy</topic><topic>Ventricular Dysfunction, Left - economics</topic><topic>Ventricular Dysfunction, Left - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hebert, Kathy A.</creatorcontrib><creatorcontrib>Horswell, Ronald L.</creatorcontrib><creatorcontrib>Dy, Sydney</creatorcontrib><creatorcontrib>Key, Ira J.</creatorcontrib><creatorcontrib>Butler, Michael K.</creatorcontrib><creatorcontrib>Cerise, Frederick P.</creatorcontrib><creatorcontrib>Arcement, Lee M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hebert, Kathy A.</au><au>Horswell, Ronald L.</au><au>Dy, Sydney</au><au>Key, Ira J.</au><au>Butler, Michael K.</au><au>Cerise, Frederick P.</au><au>Arcement, Lee M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mortality benefit of a comprehensive heart failure disease management program in indigent patients</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2006-02-01</date><risdate>2006</risdate><volume>151</volume><issue>2</issue><spage>478</spage><epage>483</epage><pages>478-483</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Heart failure (HF) produces significant morbidity and mortality. Although HF disease management (HFDM) programs have been shown to decrease this morbidity, there is still a paucity of data on their effect on mortality. The objective of this study was to determine whether participation in an HFDM program would reduce mortality in an indigent population from rural Louisiana.
Proportional hazards modeling was used to determine whether patients participating in the HFDM program had improved survival compared with patients receiving traditional outpatient care at the same institution. Inclusion criteria consisted of an index hospitalization with discharge occurring between July 1, 1997, and May 30, 2002, hospital discharge diagnosis of HF, left ventricular systolic dysfunction documented during hospitalization, and at least 1 subsequent outpatient visit. Data from patients having participated in the HFDM program before their index hospitalization were excluded.
Compared with patients who were given traditional care (n = 100), HFDM patients (n = 156) were younger (56.7 vs 60 years,
P = .031), more likely to be African American (48.7% vs 33.0%,
P = .014), more likely to be uninsured (47.4% vs 27%,
P = .001), and more likely to have an ejection fraction of ≤25% (73.1% vs 36%,
P < .001). Overall comorbidity did not differ significantly between the groups. After controlling for differences in demographics, ejection fraction, and comorbidities, participation in the HFDM program was associated with a significant reduction in mortality compared with traditional care (adjusted hazard ratio .33,
P < .001).
In this indigent population, participation in an HFDM program was associated with decreased mortality compared with traditional follow-up care.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>16442918</pmid><doi>10.1016/j.ahj.2005.04.022</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-8703 |
ispartof | The American heart journal, 2006-02, Vol.151 (2), p.478-483 |
issn | 0002-8703 1097-6744 |
language | eng |
recordid | cdi_proquest_miscellaneous_70718205 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adrenergic beta-Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Biological and medical sciences Cardiology. Vascular system Disease Management Drug therapy Female Heart Heart attacks Heart Failure - drug therapy Heart Failure - economics Heart Failure - mortality Heart failure, cardiogenic pulmonary edema, cardiac enlargement Hospitalization Hospitals Humans Louisiana - epidemiology Male Medical sciences Middle Aged Mortality Odds Ratio Poverty - statistics & numerical data Program Evaluation Proportional Hazards Models Retrospective Studies Survival Analysis Ventricular Dysfunction, Left - drug therapy Ventricular Dysfunction, Left - economics Ventricular Dysfunction, Left - mortality |
title | Mortality benefit of a comprehensive heart failure disease management program in indigent patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A16%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mortality%20benefit%20of%20a%20comprehensive%20heart%20failure%20disease%20management%20program%20in%20indigent%20patients&rft.jtitle=The%20American%20heart%20journal&rft.au=Hebert,%20Kathy%20A.&rft.date=2006-02-01&rft.volume=151&rft.issue=2&rft.spage=478&rft.epage=483&rft.pages=478-483&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/j.ahj.2005.04.022&rft_dat=%3Cproquest_cross%3E70718205%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504620964&rft_id=info:pmid/16442918&rft_els_id=S0002870305004412&rfr_iscdi=true |